glutamic acid and Feeding and Eating Disorders

glutamic acid has been researched along with Feeding and Eating Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Antinora, C; Brandon, MP; Caron, MG; Chakravarty, MM; Duriez, P; El Mestikawy, S; Favier, M; Gallino, D; Germann, J; Gorwood, P; Gratton, A; Herzallah, MM; Jacobsen, JP; Janickova, H; Justo, D; Kang, JI; Kljakic, O; Meng, XQ; Moquin, L; Natsheh, JY; Neto, PR; Pascoal, TA; Prado, MA; Prado, VF; Raulic, S; Runtz, L; Vigneault, E1
Kalita, J; Kumar, V; Misra, UK; Parashar, V1
Cottencin, O; Guardia, D; Karila, L; Rolland, B1
Hermanussen, M; Tresguerres, JA1

Reviews

1 review(s) available for glutamic acid and Feeding and Eating Disorders

ArticleYear
GABAergic and glutamatergic modulation in binge eating: therapeutic approach.
    Current pharmaceutical design, 2011, Volume: 17, Issue:14

    Topics: Animals; Binge-Eating Disorder; Bulimia Nervosa; Drug Delivery Systems; Feeding and Eating Disorders; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Reward

2011

Other Studies

3 other study(ies) available for glutamic acid and Feeding and Eating Disorders

ArticleYear
Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating.
    The Journal of clinical investigation, 2020, 12-01, Volume: 130, Issue:12

    Topics: Acetylcholine; Adult; Animals; Corpus Striatum; Donepezil; Feeding and Eating Disorders; Feeding Behavior; Female; Glutamic Acid; Humans; Interneurons; Levodopa; Male; Mice; Mice, Knockout; Middle Aged; Vesicular Acetylcholine Transport Proteins

2020
Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.
    Molecular neurobiology, 2021, Volume: 58, Issue:11

    Topics: Adolescent; Adult; Behavioral Symptoms; Brain Mapping; Cognition Disorders; Copper; Feeding and Eating Disorders; Female; Glutamic Acid; Hallucinations; Hepatolenticular Degeneration; Humans; Liver; Magnetic Resonance Imaging; Male; Mood Disorders; Movement Disorders; Neuroimaging; Neurotransmitter Agents; Quetiapine Fumarate; Severity of Illness Index; Young Adult

2021
A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders.
    Economics and human biology, 2005, Volume: 3, Issue:2

    Topics: Adult; Anti-Obesity Agents; Calcium Channel Blockers; Calcium Channels; Excitatory Amino Acid Antagonists; Feeding and Eating Disorders; Female; Germany; Glutamic Acid; Humans; Ion Channel Gating; Memantine

2005